AAAAAA
Results:
1-18
|
Results: 18
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Mabro, M
Artru, P
Gilles, V
Lotz, JP
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7), EUR J CANC, 37(8), 2001, pp. 1000-1005
Authors:
Louvet, C
Andre, T
Hammel, P
Selle, F
Landi, B
Cattan, S
Fonck, M
Flesch, M
Colin, P
Balosso, J
Ruszniewski, P
de Gramont, A
Citation: C. Louvet et al., Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM), ANN ONCOL, 12(5), 2001, pp. 675-679
Authors:
Andre, T
Colin, P
Louvet, C
Gamelin, E
Bouche, O
Achille, E
Colbert, N
Boaziz, C
Piedbois, P
Tubiana-Mathieu, N
Boutan-Laroze, A
Flesch, M
Billiau, V
Buyse, M
de Gramont, A
Citation: T. Andre et al., Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminarysafety results, SEMIN ONCOL, 28(1), 2001, pp. 35-40
Authors:
Tournigand, C
Louvet, C
Molitor, JL
Dehni, N
Lejeune, V
Sezeur, A
Pigne, A
Marpeau, L
Cady, J
de Gramont, A
Citation: C. Tournigand et al., Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma, GYNECOL ONC, 83(2), 2001, pp. 198-204
Authors:
Louvet, C
de Gramont, A
Tournigand, C
Artru, P
Maindrault-Goebel, F
Krulik, M
Citation: C. Louvet et al., Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma, CANCER, 91(11), 2001, pp. 2033-2038
Authors:
Andre, T
Louvet, C
Maindrault-Goebel, F
de Gramont, A
Citation: T. Andre et al., Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer, B CANCER, 88, 2001, pp. S20-S25
Authors:
Bensmaine, MA
Marty, M
de Gramont, A
Brienza, S
Levi, F
Ducreux, M
Francois, E
Gamelin, E
Bleiberg, H
Cvitkovic, E
Citation: Ma. Bensmaine et al., Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients, BR J CANC, 85(4), 2001, pp. 509-517
Authors:
Bensmaine, MA
de Gramont, A
Brienza, S
Marty, M
Levi, F
Ducreux, M
Francois, E
Gamelin, E
Bleiberg, H
Bleuzen, P
Simon, J
Cvitkovic, E
Citation: Ma. Bensmaine et al., Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/- folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients, EUR J CANC, 36(18), 2000, pp. 2335-2343
Authors:
Louvet, C
Coudray, AM
Tournigand, C
Prevost, S
Raymond, E
de Gramont, A
Chazard, M
Gespach, C
Citation: C. Louvet et al., Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice, ANTI-CANC D, 11(7), 2000, pp. 579-582
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles, V
Lotz, JP
Tournigand, C
Mabro, M
Molitor, JL
Artru, P
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer, ANN ONCOL, 11(11), 2000, pp. 1477-1483
Authors:
de Gramont, A
Figer, A
Seymour, M
Homerin, M
Hmissi, A
Cassidy, J
Boni, C
Cortes-Funes, H
Cervantes, A
Freyer, G
Papamichael, D
Le Bail, N
Louvet, C
Hendler, D
de Braud, F
Wilson, C
Morvan, F
Bonetti, A
Citation: A. De Gramont et al., Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J CL ONCOL, 18(16), 2000, pp. 2938-2947
Authors:
Mabro, M
de Gramont, A
Citation: M. Mabro et A. De Gramont, Aspirin against cancer., REV MED IN, 21, 2000, pp. 60S-67S
Authors:
Morel, P
Monconduit, M
Jacomy, D
Lenain, P
Grosbois, B
Bateli, C
Facon, T
Dervite, I
Bauters, F
Najman, A
de Gramont, A
Wattel, E
Citation: P. Morel et al., Prognostic factors in Waldenstrom macroglobulinemia: a report on 232 patients with the description of a new scoring system and its validation on 253 other patients, BLOOD, 96(3), 2000, pp. 852-858
Authors:
Maindrault-Goebel, F
Louvet, C
Andre, T
Carola, E
Lotz, JP
Molitor, JL
Garcia, ML
Gilles-Amar, V
Izrael, V
Krulik, M
de Gramont, A
Citation: F. Maindrault-goebel et al., Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6), EUR J CANC, 35(9), 1999, pp. 1338-1342
Authors:
Andre, T
Louvet, C
Maindrault-Goebel, F
Couteau, C
Mabro, M
Lotz, JP
Gilles-Amar, V
Krulik, M
Carola, E
Izrael, V
de Gramont, A
Citation: T. Andre et al., CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer, EUR J CANC, 35(9), 1999, pp. 1343-1347
Authors:
Andre, T
Bensmaine, MA
Louvet, C
Francois, E
Lucas, V
Desseigne, F
Beerblock, K
Bouche, O
Carola, E
Merrouche, Y
Morvan, F
Dupon-Andre, G
de Gramont, A
Citation: T. Andre et al., Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracilinfusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen, J CL ONCOL, 17(11), 1999, pp. 3560-3568
Authors:
Mabro, M
Gilles-Amar, V
Louvet, C
Carola, E
Maindrault-Goebel, F
de Gramont, A
Krulik, M
Citation: M. Mabro et al., Bimonthly fluorouracil in elderly patients with metastatic colorectal cancer: a report of 50 patients., REV MED IN, 20(10), 1999, pp. 863-868
Authors:
Andre, T
Louvet, C
Raymond, E
Tournigand, C
de Gramont, A
Citation: T. Andre et al., Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen, ANN ONCOL, 9(11), 1998, pp. 1251-1253
Risultati:
1-18
|